Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

MG Crespo‐Leiro, M Metra, LH Lund… - European journal of …, 2018 - Wiley Online Library
This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Heart rate variability (HRV): From brain death to resonance breathing at 6 breaths per minute

AR Schwerdtfeger, G Schwarz, K Pfurtscheller… - Clinical …, 2020 - Elsevier
Heart rate variability (HRV) has been associated with various diseases and reflects
autonomic cardiac control sensitive to central nervous system function. Examples of the …

2019 EACTS Expert Consensus on long-term mechanical circulatory support

EV Potapov, C Antonides… - European Journal of …, 2019 - academic.oup.com
Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

[HTML][HTML] Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock

L Wert, A Chatterjee, G Dogan, JS Hanke… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Background Left ventricular assist device (LVAD)(HVAD, Medtronic, Minneapolis, MN, USA)
implantation is already a widely accepted treatment option for end-stage heart failure (HF) …

Right ventricular failure after left ventricular assist device placement—the beginning of the end or just another challenge?

KR Turner - Journal of cardiothoracic and vascular anesthesia, 2019 - Elsevier
Left ventricular assist device (LVAD) therapy has greatly improved outcomes in patients with
end-stage heart failure. However, development of right ventricular failure (RVF) in LVAD …

[HTML][HTML] Telemonitoring of left-ventricular assist device patients—current status and future challenges

N Reiss, T Schmidt, M Boeckelmann… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
E-health, especially telemedicine, has undergone a remarkably dynamic development over
the past few years. Most experience is currently in the field of telemedical care for heart …

The history of durable left ventricular assist devices and comparison of outcomes: HeartWare, HeartMate II, HeartMate 3, and the future of mechanical circulatory …

C Berardi, CA Bravo, S Li, M Khorsandi… - Journal of Clinical …, 2022 - mdpi.com
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has
doubled in the past ten years and is bound to continue to increase. Since the first of these …

First series of left ventricular assist device exchanges to HeartMate 3

JS Hanke, SV Rojas, G Dogan… - European Journal of …, 2017 - academic.oup.com
OBJECTIVES: Left ventricular assist device (LVAD) exchange is becoming a standard
surgical procedure. The exchange procedure is an opportunity to upgrade patients to a new …

[HTML][HTML] The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD)

A Chatterjee, C Feldmann, JS Hanke… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Left ventricular assist devices (LVADs) are emerging as the treatment of choice for advanced
heart failure due to the dearth of healthy donor hearts for cardiac transplantation. The …

[HTML][HTML] Initial experience with telemonitoring in left ventricular assist device patients

S Hohmann, C Veltmann, D Duncker… - Journal of Thoracic …, 2019 - ncbi.nlm.nih.gov
Background Left ventricular assist devices (LVAD) are increasingly used in patients with end
stage heart failure. The HeartAssist 5 and aVAD LVADs offer telemetric monitoring …